Guided Therapeutics, Inc. is a medical technology company focused on developing medical devices. The Company’s primary focus is the development of its LuViva non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, especially esophageal. The Company’s technology, including products in research and development, primarily relate to biophotonics technology for the non-invasive detection of cancers. LuViva is a non-invasive cervical cancer detection product, based on the Company's biophotonic technology. The device is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix. The Company's product, in addition to detecting the structural changes attributed to cervical cancer, is also designed to detect the biochemical changes that precede the development of visual lesions.
|Headquarters||5835 Peachtree Cors E Ste D|
NORCROSS, GA, United States 30092-3413
|Independent Chairman and Director||Michael James|
|President, Chief Executive Officer and Acting Chief Financial Officer||Gene Cartwright|
|Senior Vice President - Engineering||Richard Fowler|
|Independent Director||Ronald Hart|
|Independent Director||John Imhoff|
|Shares Out.||106.8M||Book Value||$-0.05|
|Guided Therapeutics Inc does not pay a dividend.||P/E||--|
|P/Cash Flow (TTM)||--|
*GAAP = prior to non-GAAP analyst adjusted earnings.